PHASEBIO PHARMACEUTICALS INC's ticker is and the CUSIP is 717224909. A total of 2 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -98.6% | 0.00% | – |
| Q4 2021 | $19,000 | +58.3% | 7,200 | +80.0% | 0.00% | – |
| Q3 2021 | $12,000 | -76.9% | 4,000 | -71.6% | 0.00% | – |
| Q2 2021 | $52,000 | +5100.0% | 14,100 | +3425.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 400 | +100.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 200 | -71.4% | 0.00% | – |
| Q3 2020 | $2,000 | -93.3% | 700 | -89.2% | 0.00% | – |
| Q2 2020 | $30,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 6,500 | $30,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3 | $1,000 | 0.00% |